Vanda Pharmaceuticals
VNDA
#8042
Rank
$0.34 B
Marketcap
$5.80
Share price
-2.68%
Change (1 day)
28.60%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.13 Billion USD

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are $0.13 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.11 B13.65%
2023-12-31$0.10 B-3.29%
2022-12-31$0.10 B20.46%
2021-12-31$88.86 M10.82%
2020-12-31$80.19 M10.15%
2019-12-31$72.8 M28.38%
2018-12-31$56.7 M-23.41%
2017-12-31$74.03 M-6.33%
2016-12-31$79.04 M-1.22%
2015-12-31$80.02 M635.03%
2014-12-31$10.88 M-89.03%
2013-12-31$99.22 M-20.96%
2012-12-31$0.12 B-15.82%
2011-12-31$0.14 B-14.95%
2010-12-31$0.17 B-13.48%
2009-12-31$0.20 B5078.98%
2008-12-31$3.91 M-70.2%
2007-12-31$13.13 M38.18%
2006-12-31$9.5 M86.78%
2005-12-31$5.08 M181.31%
2004-12-31$1.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 88,480.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$79.60 B 58,805.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$117.21 B 86,634.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 63,076.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 61,135.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$66.37 B 49,014.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
$0.26 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA